Stockreport

Passage Bio to Report Second Quarter 2022 Financial Results on August 4, 2022

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, July 28, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative thera [Read more]